鉴于此严峻情况，诺和诺德已正式向美国食品药品监督管理局（FDA）提出申请，要求禁止生产Wegovy和Ozempic的仿制药。公司方面强调，这两种药物结构复杂，现有制药商难以确保仿制药的安全性。

【ITBEAR】诺和诺德公司近日向美国食品药品监督管理局（FDA）提交申请，请求禁止生产其畅销减肥药Wegovy和Ozempic的仿制药。据公司首席财务官Karsten Munk ...

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

On October 3, Amy Kane, 35, who once weighed 300 pounds at her heaviest, garnered 1.7 million views (@amyinhalf) after ...

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

Recent clinical studies have revealed groundbreaking developments in treating knee osteoarthritis through metabolic ...

You can now get a prescription for weight loss drugs like Ozempic from an online telehealth Visit. But iis it safe?"It’s hard ...

减重药物Ozempic的升级版 ...

在全球肥胖问题愈演愈烈的背景下，诺和诺德（Novo ...

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...